Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis

Georgina Arrambide; Carmen Espejo; Jennifer Yarden; Ella Fire; Larissa Spector; Nir Dotan; Avinoam Dukler; Alex Rovira; Xavier Montalban; Mar Tintore

doi:10.1371/journal.pone.0059953

Loading metrics

Open Access

Peer-reviewed

Research Article

Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis

Georgina Arrambide ,

Contributed equally to this work with: Georgina Arrambide, Carmen Espejo

Affiliation Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
⨯
Carmen Espejo ,

Contributed equally to this work with: Georgina Arrambide, Carmen Espejo

Affiliation Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
⨯
Jennifer Yarden,

Affiliation Department of Research and Development, Glycominds, Modi’in, Israel
⨯
Ella Fire,

Affiliation Department of Research and Development, Glycominds, Modi’in, Israel
⨯
Larissa Spector,

Affiliation Department of Research and Development, Glycominds, Modi’in, Israel
⨯
Nir Dotan,

Affiliation Department of Research and Development, Glycominds, Modi’in, Israel
⨯
Avinoam Dukler,

Affiliation Department of Research and Development, Glycominds, Simi Valley, California, United States of America
⨯
Alex Rovira,

Affiliation Magnetic Resonance Unit (IDI), Vall d’Hebron University Hospital, Barcelona, Spain
⨯
Xavier Montalban,

Affiliation Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
⨯
Mar Tintore

* E-mail: mtintore@vhebron.net

Affiliation Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
⨯

Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis

Georgina Arrambide,
Carmen Espejo,
Jennifer Yarden,
Ella Fire,
Larissa Spector,
Nir Dotan,
Avinoam Dukler,
Alex Rovira,
Xavier Montalban,
Mar Tintore

Published: March 28, 2013
https://doi.org/10.1371/journal.pone.0059953

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Multiple sclerosis
Is the Subject Area "Multiple sclerosis" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Cerebrospinal fluid
Is the Subject Area "Cerebrospinal fluid" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Multivariate analysis
Is the Subject Area "Multivariate analysis" applicable to this article?

Thanks for your feedback.
Autoimmune diseases
Is the Subject Area "Autoimmune diseases" applicable to this article?

Thanks for your feedback.